Back to Blog

Defensive Publication: When Not to Patent

April 26, 2026 Aruna 16 min read
defensive publication — intellectual property law and protection

Not every invention should be patented. Sometimes the smartest IP strategy is to make an invention publicly available in a way that prevents anyone — including competitors — from patenting it. This is defensive publication: the deliberate disclosure of an invention in a publicly accessible format to create prior art that invalidates future patent applications covering the same technology. PerspireIP helps clients make the strategic choice between patenting, trade secret protection, and defensive publication to optimize their IP portfolios.

What Is Defensive Publication?

Defensive publication is the intentional disclosure of a technical innovation through channels that create searchable, dated prior art. Once published, the disclosure prevents patent examiners from granting patents to anyone — including the publishing company itself — on the same innovation. The most commonly used defensive publication venues include the IP.com Prior Art Database (specifically designed for defensive publication), technical journals and conference proceedings, detailed product manuals and specifications, company technical blogs, and standards body contributions. The publication must be sufficiently detailed that a person of ordinary skill in the relevant technology area could understand the invention from the disclosure.

The Statutory Machinery: Section 102(a)(1) and the One-Year Clock

The strategy only works because of a specific statutory mechanism, and the mechanism has a sting in it that is easy to miss.

Under 35 U.S.C. § 102(a)(1), a person is not entitled to a patent if the claimed invention was patented, described in a printed publication, in public use, on sale, or otherwise available to the public before the effective filing date. Those last five words, added by the America Invents Act, are what give a deliberate disclosure its force: once the subject matter is available to the public, it is prior art against everyone’s later filing, worldwide, with no geographic or language limitation and no need for anyone to have actually read it.

But § 102 does not treat your own disclosure the same way it treats a stranger’s. Section 102(b)(1)(A) provides that a disclosure made one year or less before your own effective filing date is not prior art against your claimed invention if the disclosure was made by the inventor, a joint inventor, or someone who obtained the subject matter from them. In plain terms, publishing starts a one-year fuse on your own ability to patent the same thing in the United States. Publish today, and you have twelve months to change your mind and file. On day 366 your own paper is cited against you.

Section 102(b)(1)(B) supplies the other half, and it is the provision that makes early disclosure genuinely protective. Where a third party discloses the same subject matter after you have publicly disclosed it, that later third-party disclosure is also excepted from prior art against you. Going public first therefore does more than block rivals from patenting the idea — it insulates your own eventual application from intervening disclosures of the same material during your grace year.

Three limits on all of this deserve stating plainly, because overstating the protection is the most common error in this area:

  • It does not reach back. A disclosure published today is no obstacle to a competitor’s application filed yesterday. Against an earlier-filed application you have no answer under § 102 at all, which is why timing against a known competitor programme matters more than thoroughness.
  • It only blocks what it actually describes. The exception and the prior-art effect both track the subject matter disclosed. A thin, high-level write-up blocks a thin, high-level claim and leaves every implementation detail available to be patented around you.
  • The grace period is personal and American. It protects the inventor’s own disclosure, not a licensee’s independent publication, and it has no equivalent in most of the world.

Europe Has No Grace Period: Article 54(2) EPC

This is the part that turns a sound US decision into an irreversible global one, and it is the single most expensive misunderstanding in the field.

Article 54(2) EPC defines the state of the art as everything made available to the public by means of a written or oral description, by use, or in any other way, before the date of filing of the European application. There is no twelve-month allowance for the applicant’s own publication and no inventor exception. The moment the description is public, European novelty in that subject matter is gone — including yours.

Article 55 EPC is the only relief, and it is far narrower than practitioners hope. It disregards a disclosure occurring no earlier than six months before filing in just two situations: where the disclosure was due to an evident abuse in relation to the applicant or their legal predecessor, and where the invention was displayed at an official or officially recognised international exhibition within the meaning of the Convention on International Exhibitions. Neither covers a voluntary technical publication. A deliberate disclosure is precisely what Article 55 does not excuse.

The sequencing rule that follows is simple and non-negotiable: file before you publish, or accept that you are giving up patent rights outside the United States. In practice that means one of two orders of operations.

  • Publish-only, deliberately. You have decided this subject matter will never be patented anywhere, and the point is purely to spoil the art. Publish, and document that the decision was taken knowingly.
  • File a provisional or a first filing, then publish. A US provisional or any Paris Convention first filing fixes a date; a publication after that date does not destroy the novelty of what the first filing already described. This is the route to take whenever foreign rights have any plausible value, and the marginal cost over publishing alone is small.

The same logic applies with local variations across most of the world: a handful of jurisdictions offer six- or twelve-month grace periods of their own, but they differ on scope, on what triggers them and on whether a formal statement is required at filing. None of them should be relied on in place of filing first.

Statutory Invention Registration Is Gone

Anyone working from older guidance will come across the suggestion of publishing through the USPTO itself, by abandoning an application in favour of a statutory invention registration. That route no longer exists, and it is worth knowing why.

A statutory invention registration under former 35 U.S.C. § 157 let an applicant waive the right to a patent and have the Office publish the application instead. The result was not an enforceable patent, but it was official USPTO prior art with the filing date behind it — attractive precisely because the agency’s own publication was unimpeachable as to date and accessibility.

Section 157 was repealed by the America Invents Act, Public Law 112–29, § 3(e), with effect from 16 March 2013. Requests filed on or after that date are not accepted. The repeal made sense in context: under first-inventor-to-file, ordinary pre-grant publication at eighteen months already produces prior art dated to the filing, so the special mechanism was redundant.

What replaces it is more flexible, if slightly less tidy. A filed application that is allowed to publish at eighteen months, then abandoned, achieves much the same result through ordinary procedure — and keeps the option of prosecuting it open until the decision has to be made. Alternatively, an application can be published earlier on request. Weigh these against a direct technical publication:

  • File, publish at eighteen months, abandon. Prior art dated to the filing date, an unimpeachable publication, and a full year and a half to reconsider — at the cost of filing fees and the eighteen-month wait.
  • Direct publication in a dated technical venue. Effective within days and far cheaper, but you carry the burden of proving public accessibility as of the date you claim.
  • Request early publication of a pending application. A middle path that compresses the wait while keeping the agency’s date stamp.

Proving the Disclosure Was Publicly Accessible

A disclosure is only worth what you can later prove about it. The question in a dispute is never whether you published, but whether the document was publicly accessible as of a particular date — and that is a question of evidence, not intention.

The Federal Circuit has set the bar in two directions. In In re Hall, 781 F.2d 897 (Fed. Cir. 1986), a single doctoral thesis, catalogued and shelved in one German university library, was held to be a printed publication — proof that volume of readership is irrelevant where the document was genuinely retrievable. In In re Klopfenstein, 380 F.3d 1345 (Fed. Cir. 2004), a poster displayed at professional meetings was a printed publication even though no copies were distributed and nothing was indexed, the court weighing length of display, the expertise of the audience, expectations of confidentiality and the ease with which it could be copied.

Taken together they explain why venue selection is an evidential decision rather than an editorial one. A document posted to a corporate blog and later quietly revised is weak evidence; a paper in an indexed, archived, dated venue is strong evidence that proves itself years later without a witness.

  • Prefer indexed and archived venues — a journal or disclosure service with an ISSN or DOI, a repository with immutable records, a standards body’s published contribution. Indexing is what makes a document findable by a person of ordinary skill, which is the test courts actually apply.
  • Fix the date independently. A venue-issued timestamp, a DOI registration record or a trusted archive snapshot beats your own file metadata, which an opponent will characterise as self-serving.
  • Never silently revise. If the content changes, publish a dated new version. An edited page undermines the date of everything on it.
  • Keep the disclosure retrievable. A dead link is an invitation to argue the document was never accessible. Mirror it, or use a venue that guarantees persistence.
  • Write it as an enabling disclosure. The prior-art effect reaches only what the document teaches a skilled reader to do. Working examples, dimensions, tolerances, materials and alternatives are what convert a vague idea into art that genuinely blocks a claim.

That final point is the one most often economised on, and it is the one that decides whether the exercise was worth doing. A two-page summary is cheap to produce and cheap to design around. A detailed, enabling, properly dated description in an indexed venue is a durable obstacle, and the extra effort it takes is trivial next to the cost of the patent you chose not to file.

When Defensive Publication Is the Right Choice

Defensive publication is most appropriate in situations where patenting would cost more than the protection is worth, where the technology should be freely available to the industry (including to the publishing company), or where keeping the technology as a trade secret is not feasible because it will inevitably be reverse-engineered from products on the market. Specific scenarios where defensive publication beats patenting:

  • Improvements to core technology that are incremental rather than breakthrough — not worth $15,000 in filing and prosecution costs but important enough to keep free of third-party patents
  • Technology in a field where you want to prevent a competitor from patenting an obvious next step in development
  • Open-source projects where patent protection would be contrary to the project’s philosophy but you want to prevent others from patenting and then asserting against open-source users
  • Technologies that will be widely independently discovered and where you simply want to ensure freedom to operate rather than a competitive moat
  • Manufacturing process improvements that are disclosed by the physical structure of your products

Defensive Publication vs. Trade Secrets

The alternative to defensive publication is often keeping the technology as a trade secret. Trade secret protection is appropriate when the technology cannot be reverse-engineered from commercial products, when it provides durable competitive advantage, and when you can maintain secrecy through reasonable confidentiality measures. Defensive publication is preferable when secrecy is not maintainable — because the technology is inherent in a product anyone can buy and analyze. Publishing defensively in that situation costs nothing and prevents competitors from filing blocking patents, while trade secret protection in that same scenario provides illusory protection that evaporates upon the first reverse engineering effort.

How to Execute an Effective Defensive Publication

A defensive publication must be detailed enough to constitute effective prior art. Vague or high-level disclosures do not prevent competitors from patenting specific implementations. Best practices for defensive publication include:

  • Describe the technical problem and the invention’s solution in enough detail to enable a skilled reader to reproduce it
  • Include claims-like coverage of multiple embodiments to prevent narrow workarounds
  • Include drawings or diagrams where helpful
  • Use IP.com or similar dated, indexed databases where the publication date will be clearly documented and searchable by patent examiners worldwide
  • Retain a copy of the publication with its date stamp in your IP records

Defensive Publication Programs at Large Companies

Large technology companies — IBM, Google, Microsoft, and others — have formal defensive publication programs that process hundreds or thousands of disclosures per year. IBM’s Technical Disclosure Bulletin was one of the earliest defensive publication programs. These companies use defensive publication strategically: inventions that meet the patentability bar but lack sufficient commercial relevance to justify full prosecution costs are channeled to defensive publication rather than abandoned, ensuring that the innovation creates prior art value even when patent protection is not pursued. PerspireIP recommends that any company with a formal invention disclosure program include defensive publication as a deliberate disposition option in the IDF review process.

Conclusion

Defensive publication is a powerful but often overlooked tool in the IP strategist’s toolkit. By intentionally creating prior art, you can block competitor patents at zero filing cost, preserve your freedom to operate, and build a portfolio of defensive disclosures that complements your patent protection. The optimal IP strategy uses all available tools — patents, trade secrets, and defensive publication — in the combination best suited to each innovation’s characteristics and commercial context. PerspireIP provides the strategic guidance to make these decisions correctly.

Defensive Publication Best Practices for Software Companies

Software companies face particular challenges in deciding between patenting and defensive publication. The Alice doctrine’s restrictions on software patent eligibility mean that some software innovations that are genuinely novel and commercially important cannot be patented — or can only be patented with claims so narrow that they provide little competitive protection. For these innovations, defensive publication offers real value: even if you cannot patent the concept, publishing a detailed technical disclosure prevents competitors from patenting it and potentially blocking your ability to practice it.

Google, IBM, and Microsoft all use defensive publication extensively for software innovations that do not meet the current patent eligibility threshold — a pragmatic response to Alice-era restrictions that preserves freedom to operate even when patent protection is unavailable.

The IP.com Database and Other Defensive Publication Venues

IP.com’s Prior Art Database is the most widely used defensive publication venue because it is specifically designed to create searchable, indexed prior art that patent examiners worldwide can access. The database is indexed by the USPTO, EPO, CNIPA, and other major patent offices, meaning that an IP.com publication is highly likely to be found by an examiner conducting a prior art search. Other effective venues include arXiv.org for academic and research-oriented disclosures, GitHub for open-source code disclosures, and company technical blogs — though the latter must be clearly dated and accessible to qualify reliably as prior art.

For maximum effectiveness, choose venues that are specifically indexed by patent offices, provide clear dated evidence of disclosure, and are broadly accessible to researchers and patent examiners worldwide.

Defensive Publication and Open Source Strategy

Defensive publication and open-source software strategy are natural complements. When a company releases code as open source, it creates a public disclosure of any inventive technical approaches implemented in that code — an automatic defensive publication that prevents competitors from patenting those approaches. Companies with deliberate open-source strategies (Google with Android, Facebook with React, Microsoft with many developer tools) use open-source release as a conscious defensive IP tool, ensuring that the technical approaches they want kept free from patent encumbrance are published as prior art.

PerspireIP advises clients on how to coordinate open-source release decisions with patent filing decisions — ensuring that innovations worth patenting are filed before open-source release, while innovations that should be kept free are released to create definitive prior art.

Monitoring and Enforcing Against Patents Filed After Your Defensive Publication

Defensive publication only works as a prior art defense if the patent office actually finds and applies the publication during examination. Unfortunately, examiners sometimes miss relevant prior art — including defensive publications that should have blocked a patent from issuing. When a competitor is granted a patent on technology you defensively published before their filing date, you have several options: submit the defensive publication during prosecution through a third-party submission if the patent application is still pending; file an inter partes review after the patent issues, citing your defensive publication as invalidating prior art; or raise the prior art as an invalidity defense if you are ever sued on the patent.

PerspireIP maintains records of all defensive publications it helps clients create and monitors for potentially conflicting patent grants that may require IPR or other validity challenge proceedings.

Practical Tips for Implementation

Translating IP strategy into day-to-day practice requires discipline, clear ownership, and the right support structures. The most successful IP programs share a common set of operational characteristics: IP responsibilities are embedded in standard business processes rather than treated as external compliance requirements; senior leadership reviews IP metrics alongside financial and operational KPIs; the IP team has a direct line to the business strategy function; and outside counsel relationships are managed to align incentives with outcomes rather than rewarding billable hours.

PerspireIP works as an embedded IP strategy partner — providing the expertise and execution capability that most companies cannot build internally at a fraction of the cost of a full in-house IP department. Whether you are a startup building your first patent application or a mid-market company scaling a licensing program, the fundamentals of successful IP strategy are consistent: be deliberate, be systematic, be aligned with business goals, and review regularly.

Common Pitfalls to Avoid

Even companies with sophisticated IP programs fall into predictable traps. Over-investment in non-core technology areas — filing patents on innovations that will never be commercialized or licensed — wastes budget that could better support core portfolio development. Under-investment in international filing leaves key markets unprotected and competitors free to copy. Failing to review and prune aging patents results in mounting maintenance costs for assets that no longer serve the business. Treating IP counsel as a cost center rather than a business partner results in reactive, transactional legal work instead of proactive strategy.

And failing to communicate IP value to the board and investors leads to under-appreciation of IP assets that should be enhancing company valuation. PerspireIP helps clients avoid all of these pitfalls through structured IP program management, regular portfolio reviews, and clear IP value communication to stakeholders at every level of the organization.

Working With PerspireIP

PerspireIP offers a comprehensive suite of IP strategy and management services designed to meet clients where they are and take them where they want to go. Our services span IP audits and portfolio assessments, patent and trademark prosecution strategy, licensing program design and execution, IP due diligence for M&A transactions, freedom-to-operate analysis, IP enforcement strategy, and ongoing IP portfolio management. We bring deep technical expertise across technology, life sciences, consumer products, and industrial sectors, combined with the business acumen to connect IP decisions to commercial outcomes. Our clients range from pre-revenue startups filing their first provisional applications to Fortune 500 companies managing global licensing programs.

What they share is a commitment to treating IP as the strategic business asset it is — and a recognition that expert IP strategy support pays for itself many times over in stronger competitive position, better deal outcomes, and more effective use of IP budget resources. Contact PerspireIP today to discuss how we can help strengthen your IP strategy and maximize the value of your intellectual property assets.